LCM

Lynx1 Capital Management Portfolio holdings

AUM $346M
1-Year Est. Return 2.97%
This Quarter Est. Return
1 Year Est. Return
-2.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$388M
AUM Growth
+$134M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
17
New
Increased
Reduced
Closed

Top Buys

1
+$16.8M
2
+$15.7M
3
+$9.99M
4
SLN
Silence Therapeutics
SLN
+$6.28M
5
PASG icon
Passage Bio
PASG
+$6.03M

Top Sells

1
+$61.9M
2
+$2.99M
3
+$2.84M
4
CABA icon
Cabaletta Bio
CABA
+$468K
5
PVLA
Palvella Therapeutics
PVLA
+$183K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$89.3M 23.01%
2,253,183
-1,560,743
2
$68M 17.5%
1,509,007
+373,782
3
$49.9M 12.85%
3,696,820
+739,902
4
$41.5M 10.68%
5,224,600
5
$35.5M 9.15%
2,082,973
-27,428
6
$35.3M 9.09%
3,310,563
+1,471,946
7
$29.7M 7.65%
3,634,662
+500,266
8
$11.4M 2.93%
526,642
+290,855
9
$8.87M 2.28%
1,390,160
-468,249
10
$6.54M 1.69%
242,294
+223,336
11
$5.27M 1.36%
1,981,106
-15,900
12
$2.44M 0.63%
+600,000
13
$1.93M 0.5%
137,923
+9,310
14
$1.61M 0.41%
109,740
-12,458
15
$839K 0.22%
67,872
-820
16
$197K 0.05%
+17,400
17
– –
-702,415